<DOC>
	<DOCNO>NCT01220076</DOCNO>
	<brief_summary>The biological response treatment tamoxifen preoperative situation study protocol . This study enroll patient non-metastatic breast cancer HR + . The relationship CYP2D6 polymorphism , pharmacokinetics biological efficacy TAM study .</brief_summary>
	<brief_title>Biological Response Tamoxifen ( TAM ) Patients With Breast Cancer Non Metastatic RH+</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Adult Females ( ≥ 18 year ) , effective contraception . The contraceptive use estrogen derivative . It must continue treatment tamoxifen least two month arrest . histologically confirm diagnosis invasive breast cancer , previously untreated . Patients support breast cancer may include period least 2 year last systemic treatment inclusion study . Primary tumor hormonopositive : ER / PR ≥ 50 % immunostaining HR Allred score &gt; = 3 lack HER2 overexpression palpable primary tumor great equal 20 mm diameter , measure ultrasound readily operable tumor No metastases Clinical Stage M0 performance index ≤ 1 ( OMS ) Polynuclear &gt; = 1500 / mm3 , Hb Platelets &gt; = 100 000/mm3 Hb ≥10 g/dL normal liver function : bilirubin ≤ 1.5 x ULN , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 2.5 x ULN ( ≤ 5 x ULN liver metastasis ) . Normal renal function ( creatinine ≤ 1.5 mg / dL creatinine clearance ≥ 60 mL / min ) cardiac function ( MUGA scan ultrasound February &gt; 55 % ) lung function , 5.2.2 Criteria related participation study : Patient affiliate social security , Patient sign dated consent Alcohol Consumption Pregnancy , Breastfeeding Smoking Use St. John 's Wort ( herbal tea ... ) within 5 day start treatment Consumption grapefruit juice last 5 day start treatment congenital galactosemia malabsorption glucose galactose lactase deficiency Comedications may interfere cytochrome P450 : enzyme inducer progress : Antiepileptic drug : carbamazepine , phenobarbital , phenytoin Antinfectieux : rifampin , rifabutin , névrirapine , griséofilvine , efavirenz Enzyme Inhibitors progress : Inhibitors serotonin reuptake : fluoxetine , paroxetine Thioridazine . Quinidine Amiodarone Ca antagonist : diltiazem , verapamil azole antifungal ketoconazole , fluconazole , miconazole . No protease inhibitor : ritonavir , nelfinavir , amprenavir , indinavir . Macrolides : erythromycin , clarithromycin , josamycin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Tamoxifen ,</keyword>
	<keyword>Breat Cancer</keyword>
	<keyword>Pharmacogenetic</keyword>
	<keyword>non metastatic breast cancer , HR +</keyword>
</DOC>